Fauci Calls Moderna’s Coronavirus Vaccine Candidate ‘Quite Promising’

Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, is “cautiously optimistic” about Moderna Inc’s (NASDAQ: MRNA) coronavirus vaccine candidate and told NPR that, if proven successful, it could be ready for use at the end of 2020. Moderna’s stock ticked up about 4% Friday morning following his comments. What Fauci Said “Although the numbers were limited, it was quite good news because it reached and went…